Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Smoltek is demanded repayment for deductions of employer contributions

Smoltek Nanotech Holding AB (“Smoltek”) announces that the Swedish Tax Agency (Skatteverket) has decided to demand repayment for deductions made on employer contributions for employees who work with research and development. The period referred to is January 1, 2021, to March 31, 2023, and Smoltek is demanded to repay a total of SEK 1,507,516. The company will appeal the decision.The Swedish Tax Agency has decided not to allow deductions for research and development (R&D) in employer declarations where Smoltek made deductions for employer contributions relating to employees who actively

Alfa Laval Capital Markets Day 2023 – Leading the transition

Today, 2 November 2023, Alfa Laval hosted its annual Capital Markets Day. During the digital event, the management team presented the strategic direction for the company, with further details provided for each of the three divisions, as well as investment plans and an update on the company’s sustainability commitment.During the Capital Markets Day, Tom Erixon, President and CEO of Alfa Laval, elaborated on the growth strategy based for each of Alfa Laval’s three divisions. The focus for the Energy Division was on the energy transition and it was announced that Alfa Laval is creating a new

Invitation to the presentation of Arla Plast´s Q3 2023 report at 10:00 am (CET) on 9 November, 2023

Arla Plast will release the interim report for the third quarter of 2023 on Thursday 9 November, 2023 at 08:00 am (CET).Christian Krichau, President and CEO, and Monica Ljung, CFO, will present the financial result on a digital conference the same day at 10:00 am (CET). The report and a presentation will be available on www.arlaplastgroup.com. In order to participate in the conference, please email that you would like to attend to ir@arlaplast.com and you will receive a link. For further information, please contact: Monica Ljung, CFO, tel: 0141-20 38 02 Christian Krichau, CEO,

The safety imperative for ESG

2.11.2023, Firenze, Italy - Businesses are under increasing pressure to deliver effective and sustainable strategies to meet ESG expectations. To do so, managers must put health and safety at the top of the priority list. With growing emphasis on the implementation of robust corporate Environmental, Social, and Governance (ESG) strategies, safety technology specialists at Advanced Microwave Engineering (AME) are highlighting the core role of safety. For more than two decades AME has been providing high-performance, adaptable solutions for industrial applications that actively prevent

NEW THOMSON VIDEO EXPLORES SHIFT TOWARD ELECTRIFICATION OF APPLICATIONS USING LINEAR ACTUATORS

Editorial Contact: Shreyasi Bhaumik - +44 (0) 203 409 5090 Company Contact: Svenja Kirsten - +49 7022 504198 Please quote the following contact information when publishing: Phone: +44 (0) 1271 334 500, www.thomsonlinear.com; sales.europe@thomsonlinear.com NEW THOMSON VIDEO EXPLORES SHIFT TOWARD ELECTRIFICATION OF APPLICATIONS USING LINEAR ACTUATORS 02.11.2023, KRISTIANSTAD, SWEDEN – Thomson Industries, Inc, a leading manufacturer of linear motion control solutions, has released a video: 'Clean and Simple: The Electrification of Applications with Linear Actuators,' which

NEW THOMSON VIDEO EXPLORES SHIFT TOWARD ELECTRIFICATION OF APPLICATIONS USING LINEAR ACTUATORS

02.11.2023, DOWNERS GROVE, IL – Thomson Industries, Inc, a leading manufacturer of linear motion control solutions, has released a video: 'Clean and Simple: The Electrification of Applications with Linear Actuators,' which highlights the growing trend towards electric actuators and the advantages they bring over traditional technologies such as hydraulic, pneumatic and even manual actuation.For decades, hydraulic and pneumatic systems have been the preferred choice for heavy duty applications. However, these systems pose challenges, including complexity, noise, high energy consumption,

Nel ASA: Mandatory notification of trade by primary insider

(November 2, 2023 – Oslo, Norway) Charlotta Falvin, Board Member of Nel ASA (“Nel”), has today bought 46,000 shares in Nel ASA at an average share price of NOK 8.01. After the transaction, Ms. Falvin holds a total of 46,000 shares and 0 options in the company. This information is subject to the disclosure requirements in articles 19 of the Regulation EU 596/2014 (the EU Market Abuse Regulation) and section 5-12 of the Norwegian Securities Trading Act.  ENDS  About Nel ASA | www.nelhydrogen.comNel has a history tracing back to 1927 and is today a leading pure play hydrogen

Epidemic Sound artist, King Sis, invited to join TIDAL RISING program

· TIDAL adds the RnB singer-songwriter and Epidemic Sound artist, King Sis, to its up-and-coming artist program, TIDAL RISING · TIDAL RISING is a program for emerging artists so they can grow, thrive, and build their careers · The announcement follows previous industry recognition for King Sis, and comes hot on the heels of the news that Epidemic Sound has signed the multi-platinum recording artist, Jordin Sparks Stockholm, Sweden: Epidemic Sound, the market-leading soundtrack innovation platform for content creators, has today announced that King Sis 

Terveystalo Plc: Managers’ Transactions (Lemne)

Terveystalo Plc, Managers’ transactions, 2 November 2023 at 16:00 EET On 23 March 2023, Terveystalo Plc’s Annual General Meeting resolved that the annual remuneration of the Board will be paid as a combination of Company's shares and cash in such a manner that 40% of the annual remuneration is paid in the Company's shares, which will be purchased from the market on behalf of the members of the Board of Directors at a price determined in public trading, and 60% is paid in cash. Annual General Meeting also resolved that the shares will be purchased within a period of two weeks beginning

Terveystalo Plc: Managers’ Transactions (Pullola)

Terveystalo Plc, Managers’ transactions, 2 November 2023 at 16:00 EET On 23 March 2023, Terveystalo Plc’s Annual General Meeting resolved that the annual remuneration of the Board will be paid as a combination of Company's shares and cash in such a manner that 40% of the annual remuneration is paid in the Company's shares, which will be purchased from the market on behalf of the members of the Board of Directors at a price determined in public trading, and 60% is paid in cash. Annual General Meeting also resolved that the shares will be purchased within a period of two weeks beginning

Terveystalo Plc: Managers’ Transactions (Rosenberg)

Terveystalo Plc, Managers’ transactions, 2 November 2023 at 16:00 EET On 23 March 2023, Terveystalo Plc’s Annual General Meeting resolved that the annual remuneration of the Board will be paid as a combination of Company's shares and cash in such a manner that 40% of the annual remuneration is paid in the Company's shares, which will be purchased from the market on behalf of the members of the Board of Directors at a price determined in public trading, and 60% is paid in cash. Annual General Meeting also resolved that the shares will be purchased within a period of two weeks beginning

Terveystalo Plc: Managers’ Transactions (Viippola)

Terveystalo Plc, Managers’ transactions, 2 November 2023 at 16:00 EET On 23 March 2023, Terveystalo Plc’s Annual General Meeting resolved that the annual remuneration of the Board will be paid as a combination of Company's shares and cash in such a manner that 40% of the annual remuneration is paid in the Company's shares, which will be purchased from the market on behalf of the members of the Board of Directors at a price determined in public trading, and 60% is paid in cash. Annual General Meeting also resolved that the shares will be purchased within a period of two weeks beginning

Terveystalo Plc: Managers’ Transactions (Hasselberg)

Terveystalo Plc, Managers’ transactions, 2 November 2023 at 16:00 EET On 23 March 2023, Terveystalo Plc’s Annual General Meeting resolved that the annual remuneration of the Board will be paid as a combination of Company's shares and cash in such a manner that 40% of the annual remuneration is paid in the Company's shares, which will be purchased from the market on behalf of the members of the Board of Directors at a price determined in public trading, and 60% is paid in cash. Annual General Meeting also resolved that the shares will be purchased within a period of two weeks beginning

Terveystalo Plc: Managers’ Transactions (Kauniskangas)

Terveystalo Plc, Managers’ transactions, 2 November 2023 at 16:00 EET On 23 March 2023, Terveystalo Plc’s Annual General Meeting resolved that the annual remuneration of the Board will be paid as a combination of Company's shares and cash in such a manner that 40% of the annual remuneration is paid in the Company's shares, which will be purchased from the market on behalf of the members of the Board of Directors at a price determined in public trading, and 60% is paid in cash. Annual General Meeting also resolved that the shares will be purchased within a period of two weeks beginning

Terveystalo Plc: Managers’ Transactions (Lehtoranta)

Terveystalo Plc, Managers’ transactions, 2 November 2023 at 16:00 EET On 23 March 2023, Terveystalo Plc’s Annual General Meeting resolved that the annual remuneration of the Board will be paid as a combination of Company's shares and cash in such a manner that 40% of the annual remuneration is paid in the Company's shares, which will be purchased from the market on behalf of the members of the Board of Directors at a price determined in public trading, and 60% is paid in cash. Annual General Meeting also resolved that the shares will be purchased within a period of two weeks beginning

New from NOMOS: The icon in a luxury limited edition

The limited anniversary editions that NOMOS Glashütte produces in honor of Glashütte's watchmaking tradition are legendary—and usually sell out quickly. This fall, the watchmaking company is continuing the series with the timepiece that has been considered an icon for decades: 175 Tangente are now available in 18 kt rose gold.GLASHÜTTE, NOVEMBER 2, 2023. How best to describe Tangente rose gold neomatik - 175 Years Watchmaking Glashütte? The words dapper and sophisticated immediately come to mind—as well as chic, elegant, and stylish. With this new limited edition in rose gold, NOMOS

Swedish Export Credit Corporation (SEK) has priced new AUD 500m 7-year Benchmark

PRESS RELEASE – 2 November 2023   On Tuesday 24th October 2023, SEK, rated Aa1 / AA+ (stable / stable) by Moody’s and S&P, successfully priced a new 7-year AUD 500m Kangaroo benchmark, its second AUD 500m Kangaroo benchmark this year. The transaction, due 1st November 2030 pays a semi-annual coupon of 5.40% and was priced at a spread of SQ ASW+75bps (ACGB+91.5bps) with a reoffer yield of 5.43%. Joint Lead Managers on the transaction were Nomura, RBC Capital Markets, and TD Securities.    •       SEK issued an initial marketing announcement at 10:04am Sydney time on Friday the

Tailored to the perfect size: the new Ahoi neomatik 38 date

Compact timekeeping: the new Ahoi neomatik 38 date from NOMOS Glashütte is powered by the automatic caliber DUW 6101, which was previously only used in cases over 40 mm in diameter.GLASHÜTTE, OCTOBER 25, 2023. The NOMOS caliber DUW 6101 is something special: a slim, very efficient automatic movement developed and manufactured in-house. Until now, it was only found in watch cases with a diameter of more than 40 millimeters, but now it also fits into a smaller NOMOS watch: the new Ahoi neomatik 38 date. How? For the new ideal dimensions, the date ring of the slim movement was adjusted,

Preliminary result of Crayfish BidCo Oy’s voluntary recommended public cash tender offer for all shares in Caverion Corporation

Caverion Corporation Tender Offer 2 November 2023 at 15.10 p.m. (EET)Preliminary result of Crayfish BidCo Oy’s voluntary recommended public cash tender offer for all shares in Caverion Corporation NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE TENDER OFFER WOULD BE PROHIBITED BY APPLICABLE LAW. FOR FURTHER INFORMATION, PLEASE SEE SECTION ENTITLED “IMPORTANT INFORMATION” BELOW. Crayfish BidCo Oy has today published the following

Air Canada to establish at Stockholm Arlanda Airport – will launch two direct routes to Montreal and Toronto

Canada's largest airline, Air Canada, will establish at Stockholm Arlanda Airport with two direct routes, one of which is a new destination – Montreal – on June 12[th] as of next year. Operating direct routes to Toronto and Montreal five times a week, Air Canada will be an important addition to Stockholm Arlanda, connecting the Swedish capital with Canada as well as the North American market. Air Canada, as a founding member of Star Alliance and as the largest provider of scheduled passenger services on the domestic and international market to and from Canada, will establish at Stockholm

Elisa sells majority stake in Elisa Videra's business

ELISA INVESTOR NEWS RELEASE, 2 NOVEMBER 2023 AT 3:05 PMThe businesses of Elisa Corporation's subsidiary Elisa Videra and the German company MVC Mobile VideoCommunication GmbH (owned by KLP Vermögensverwaltungs GmbH) will be combined into MVC. KLP will have a 62.5% holding and Elisa 37.5% of MVC Videra. The transaction is being conducted as a share swap. Going forward, the company will not be consolidated into the Elisa Group. The transaction is subject to approval by authority in Finland, and the estimated closing is in December 2023. In line with its international businesses strategy,

BerGenBio Announces Poster Presentation at Upcoming ASH Meeting

BERGEN, Norway, November 2, 2023, BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical needs, today announced that a poster highlighting final results from a clinical study of its highly selective AXL inhibitor bemcentinib in patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) will be presented during the American Society of Hematology (ASH) Annual Meeting being held December 9-12, 2023 in San Diego, CA.   Poster Details: Publication Number: 4287Title: Phase Ib/II

Dr. Kevin J. Tracey receives Hans Wigzell Research Foundation’s Science Prize amounting to USD 100.000

The Hans Wigzell Research Foundation (Hans Wigzells Forskningsstiftelse) awards its annual scientific prize to Kevin J. Tracey, MD, president and CEO, at the Feinstein Institutes for Medical Research. Dr. Tracey receives the prize of USD 100.000 for his contributions to the fields of neuroscience and neuroimmunology and his pioneering discoveries in vagus nerve stimulation, the inflammatory reflex and bioelectronic medicine.   Dr. Tracey’s discovery of the body’s “inflammatory reflex” – a neural circuit regulating inflammatory responses, is on of his most important achievements. This

There are no items matching the current filter
There are no more items matching the current filter
Back to top